Campbell & Co Investment Adviser’s Orthofix Medical OFIX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25,827	Closed	-$530K	–	967
2022 Q4	$530K	Buy	+25,827	New	+$456K	0.13%	284
2021 Q3	–	Sell	-5,124	Closed	-$206K	–	713
2021 Q2	$206K	Buy	+5,124	New	+$217K	0.08%	443
2018 Q2	–	Sell	-6,701	Closed	-$394K	–	487
2018 Q1	$394K	Buy	+6,701	New	+$375K	0.33%	98

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Campbell & Co Investment Adviser's OFIX Position: Q1 2023 in Review

Campbell & Co Investment Adviser sold out of Orthofix Medical (OFIX) in Q1 2023, closing a stake of 25,827 shares — an estimated $530K sold.

Campbell & Co Investment Adviser first reported a position in OFIX in Q1 2018 and held it in 3 quarters. The position peaked at $530K in Q4 2022. 162 funds tracked by Wall St. Rank hold OFIX as of Q1 2023.

Campbell & Co Investment Adviser reported no remaining Orthofix Medical position as of Q1 2023 after selling out during the quarter.
Campbell & Co Investment Adviser sold 25,827 Orthofix Medical shares in Q1 2023, an estimated $530K.
Campbell & Co Investment Adviser first reported a position in Orthofix Medical in Q1 2018 and held it in 3 quarters.
Campbell & Co Investment Adviser's Orthofix Medical position peaked at $530K in Q4 2022.
162 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2023.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2023, filed 11 May 2023.